Evidence map›Paper›PMID 39125398›Full record

ArticleNutrients2024

Persimmon Fiber-Rich Ingredients Promote Anti-Inflammatory Responses and the Growth of Beneficial Anti-Inflammatory Firmicutes Species from the Human Colon.

Lucía López-Bermudo, Bryan Moreno-Chamba, Julio Salazar-Bermeo, Nicholas J Hayward, Amanda Morris, Gary J Duncan, Wendy R Russell, Antonio Cárdenas, Ángeles Ortega, Blanca Escudero-López and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nutrients, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Lucía López-BermudoAndalusian Center of Molecular Biology and Regenerative Medicine (CABIMER), Pablo de Olavide University, University of Seville, CSIC, 41092 Seville, Spain.
Bryan Moreno-ChambaInstitute of Research, Development and Innovation in Sanitary Biotechnology of Elche, Miguel Hernández University, 03202 Elche, Spain.ORCID 0000-0002-4263-2239
Julio Salazar-BermeoInstitute of Research, Development and Innovation in Sanitary Biotechnology of Elche, Miguel Hernández University, 03202 Elche, Spain.ORCID 0000-0002-8920-9817
Nicholas J HaywardRowett Institute, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, UK.ORCID 0000-0002-7636-3129
Amanda MorrisRowett Institute, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, UK.
Gary J DuncanRowett Institute, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, UK.
Wendy R RussellRowett Institute, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, UK.ORCID 0000-0002-6575-2305
Antonio CárdenasAndalusian Center of Molecular Biology and Regenerative Medicine (CABIMER), Pablo de Olavide University, University of Seville, CSIC, 41092 Seville, Spain.
Ángeles OrtegaAndalusian Center of Molecular Biology and Regenerative Medicine (CABIMER), Pablo de Olavide University, University of Seville, CSIC, 41092 Seville, Spain.ORCID 0000-0002-0503-5793
Blanca Escudero-LópezAndalusian Center of Molecular Biology and Regenerative Medicine (CABIMER), Pablo de Olavide University, University of Seville, CSIC, 41092 Seville, Spain.ORCID 0000-0002-4964-1306
Genoveva BernáAndalusian Center of Molecular Biology and Regenerative Medicine (CABIMER), Pablo de Olavide University, University of Seville, CSIC, 41092 Seville, Spain.ORCID 0000-0001-8185-8428
Nuria Martí BruñaInstitute of Research, Development and Innovation in Sanitary Biotechnology of Elche, Miguel Hernández University, 03202 Elche, Spain.
Sylvia H DuncanRowett Institute, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, UK.
Madalina NeacsuRowett Institute, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, UK.
Franz MartinAndalusian Center of Molecular Biology and Regenerative Medicine (CABIMER), Pablo de Olavide University, University of Seville, CSIC, 41092 Seville, Spain.

Funding

FPU contract Ministerio de Educación y Formación Profesional (Spain) FPU19/04497Instituto de Salud Carlos III (Spain) fellowship from the Training Program of the Centro de Investigación Biomédica en Red de Dia-betes y Enfermedades Metabólicas Asociadas (CIBERDEM)Miguel Hernández University Spain Ayudas a la contratación de personal investigador en formación 2022Mobility Scholarship from Santander Open Access Spain Movilidad Internacional UMH 2023 - 2da convocatoria; 02706/2023Scottish Government's Rural and Environment Science and Analytical Services Division (RESAS) Strategic Research Programme RI-B6-1Spanish Ministerio de Ciencia e Innovación PID2020-116731RB-C21
6 · The paper itself

Abstract

Persimmon fruit processing-derived waste and by-products, such as peels and pomace, are important sources of dietary fiber and phytochemicals. Revalorizing these by-products could help promote circular nutrition and agricultural sustainability while tackling dietary deficiencies and chronic diseases. In this study, fiber-rich fractions were prepared from the by-products of Sharoni and Brilliant Red persimmon varieties. These fractions were quantified for their phenolic composition and assessed for their ability to promote the growth of beneficial human colonic Firmicutes species and for their in vitro anti-inflammatory potential. Gallic and protocatechuic acids, delphinidin, and cyanidin were the main phenolics identified.

Indexed as

Anti-Inflammatory AgentsColonDietary FiberDiospyrosAnimalsAnthocyaninsBacillotaCaco-2 CellsFaecalibacterium prausnitziiFermentationFruitGallic AcidGastrointestinal MicrobiomeHumansHydroxybenzoatesInterleukin-1betaAnthocyaninsAnti-Inflammatory AgentsDietary FiberGallic AcidHydroxybenzoatesInterleukin-1betaInterleukin-6Phenolsprotocatechuic acidTumor Necrosis Factor-alphaanti-inflammatory activitybutyratedietary fiberEubacterium eligensFaecalibacterium prausntiziipectins

Identifiers

PMID39125398
PMCPMC11314113

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.